Author

Jose Ricardo McFaline-Figueroa

Herbert Irving Comprehensive Cancer CenterORCID 0000-0002-6670-1841Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Adeya Wyatt· 1 shared Charlotte BellamyiD· 1 shared Elham AziziiD· 1 shared Henry Fuchs· 1 shared José L. McFaline‐FigueroaiD· 1 shared Jose Pomarino Nima· 1 shared Justin HongiD· 1 shared Keith Lloyd LigoniD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperGenomics

Adeya Wyatt

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

A heterogeneous pharmaco-transcriptomic landscape induced by targeting a single oncogenic kinase

Ross M. Giglio, Nicholas Y. Hou, Lingting Shi, Adeya Wyatt, Justin Hong, Mathini Vaikunthan, Charlotte Bellamy, Henry Fuchs, Vivian Lu, Ndubuisi Obasi, Jose Pomarino Nima, Seth W. Malinowski, Keith Lloyd Ligon, José L. McFaline‐Figueroa, Nir Yosef, , Jose Ricardo McFaline-Figueroa

This study uses SCHEMATIC to analyze the molecular response of glioblastoma to EGFR inhibitors, identifying chemotype-specific programs and showing that combined EGFR/PI3K inhibition reduces adaptive transcription.

bioRxiv · Apr 8, 2024 · PreprintGenomics